Parvin Asset Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Parvin Asset Management’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40	Closed	–	–	424
2024 Q4	$0	Buy	+40	New	+$51	﹤0.01%	345

Parvin Asset Management's ONCT Position: Q1 2025 in Review

Parvin Asset Management sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2025, closing a stake of 40 shares.

Parvin Asset Management first reported a position in ONCT in Q4 2024 and held it in 1 quarter. The position peaked at $0 in Q4 2024. 0 funds tracked by Wall St. Rank hold ONCT as of Q1 2025.

Parvin Asset Management reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Parvin Asset Management sold 40 Oncternal Therapeutics, Inc. Common Stock shares in Q1 2025.
Parvin Asset Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Parvin Asset Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $0 in Q4 2024.
0 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Parvin Asset Management's 13F filing for Q1 2025, filed 15 May 2025.